335 related articles for article (PubMed ID: 16570136)
1. Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine.
Hemmings DG
Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):18-29. PubMed ID: 16570136
[TBL] [Abstract][Full Text] [Related]
2. Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery.
Choi SK; Ahn DS; Lee YH
Cardiovasc Res; 2009 May; 82(2):324-32. PubMed ID: 19218288
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation.
Mathieson FA; Nixon GF
Br J Pharmacol; 2006 Feb; 147(4):351-9. PubMed ID: 16402047
[TBL] [Abstract][Full Text] [Related]
4. Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: activation of non-store-operated Ca2+ entry.
Thomas GD; Snetkov VA; Patel R; Leach RM; Aaronson PI; Ward JP
Cardiovasc Res; 2005 Oct; 68(1):56-64. PubMed ID: 15950201
[TBL] [Abstract][Full Text] [Related]
5. Ca2+ signaling induced by sphingosylphosphorylcholine and sphingosine 1-phosphate via distinct mechanisms in rat glomerular mesangial cells.
Chen PF; Chin TY; Chueh SH
Kidney Int; 1998 Nov; 54(5):1470-83. PubMed ID: 9844123
[TBL] [Abstract][Full Text] [Related]
6. Sphingosylphosphorylcholine and sphingosine-1-phosphate mobilize cytosolic calcium through different mechanisms in human airway epithelial cells.
Orlati S; Porcelli AM; Hrelia S; Rugolo M
Cell Calcium; 1998 Jun; 23(6):387-94. PubMed ID: 9924630
[TBL] [Abstract][Full Text] [Related]
7. Pertussis toxin inhibits phospholipase C activation and Ca2+ mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids.
Okajima F; Kondo Y
J Biol Chem; 1995 Nov; 270(44):26332-40. PubMed ID: 7592844
[TBL] [Abstract][Full Text] [Related]
8. Effects of sphingosine-1-phosphate and sphingosylphosphorylcholine on intracellular Ca2+ and cell death in prostate cancer cell lines.
Mulders AC; Nau S; Li Y; Michel MC
Auton Autacoid Pharmacol; 2007 Oct; 27(4):173-9. PubMed ID: 18076478
[TBL] [Abstract][Full Text] [Related]
9. Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C.
Afrasiabi E; Blom T; Ekokoski E; Tuominen RK; Törnquist K
Cell Signal; 2006 Oct; 18(10):1671-8. PubMed ID: 16490345
[TBL] [Abstract][Full Text] [Related]
10. Sphingosylphosphorylcholine stimulates mitogen-activated protein kinase via a Ca2+-dependent pathway.
Chin TY; Chueh SH
Am J Physiol; 1998 Nov; 275(5):C1255-63. PubMed ID: 9814974
[TBL] [Abstract][Full Text] [Related]
11. Augmented sphingosylphosphorylcholine-induced Ca2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat.
Ryu SK; Ahn DS; Cho YE; Choi SK; Kim YH; Morgan KG; Lee YH
Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):30-6. PubMed ID: 16521007
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate receptors mediate the lipid-induced cAMP accumulation through cyclooxygenase-2/prostaglandin I2 pathway in human coronary artery smooth muscle cells.
Damirin A; Tomura H; Komachi M; Tobo M; Sato K; Mogi C; Nochi H; Tamoto K; Okajima F
Mol Pharmacol; 2005 Apr; 67(4):1177-85. PubMed ID: 15625281
[TBL] [Abstract][Full Text] [Related]
13. Sphingosylphosphorylcholine potentiates vasoreactivity and voltage-gated Ca2+ entry via NOX1 and reactive oxygen species.
Shaifta Y; Snetkov VA; Prieto-Lloret J; Knock GA; Smirnov SV; Aaronson PI; Ward JP
Cardiovasc Res; 2015 Apr; 106(1):121-30. PubMed ID: 25661082
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine.
Czyborra C; Bischoff A; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):37-44. PubMed ID: 16521006
[TBL] [Abstract][Full Text] [Related]
15. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.
Nofer JR; van der Giet M; Tölle M; Wolinska I; von Wnuck Lipinski K; Baba HA; Tietge UJ; Gödecke A; Ishii I; Kleuser B; Schäfers M; Fobker M; Zidek W; Assmann G; Chun J; Levkau B
J Clin Invest; 2004 Feb; 113(4):569-81. PubMed ID: 14966566
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction.
Coussin F; Scott RH; Wise A; Nixon GF
Circ Res; 2002 Jul; 91(2):151-7. PubMed ID: 12142348
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate modulates spiral modiolar artery tone: A potential role in vascular-based inner ear pathologies?
Scherer EQ; Lidington D; Oestreicher E; Arnold W; Pohl U; Bolz SS
Cardiovasc Res; 2006 Apr; 70(1):79-87. PubMed ID: 16533504
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors.
Meyer zu Heringdorf D; Lass H; Kuchar I; Lipinski M; Alemany R; Rümenapp U; Jakobs KH
Eur J Pharmacol; 2001 Mar; 414(2-3):145-54. PubMed ID: 11239914
[TBL] [Abstract][Full Text] [Related]
19. Sphingosylphosphorylcholine is a novel messenger for Rho-kinase-mediated Ca2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C.
Shirao S; Kashiwagi S; Sato M; Miwa S; Nakao F; Kurokawa T; Todoroki-Ikeda N; Mogami K; Mizukami Y; Kuriyama S; Haze K; Suzuki M; Kobayashi S
Circ Res; 2002 Jul; 91(2):112-9. PubMed ID: 12142343
[TBL] [Abstract][Full Text] [Related]
20. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16.
Okamoto H; Takuwa N; Yatomi Y; Gonda K; Shigematsu H; Takuwa Y
Biochem Biophys Res Commun; 1999 Jun; 260(1):203-8. PubMed ID: 10381367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
